NASDAQ:OPCH - Nasdaq - US68404L2016 - Common Stock - Currency: USD
32.63
+0.55 (+1.71%)
The current stock price of OPCH is 32.63 USD. In the past month the price increased by 3.85%. In the past year, price increased by 1.59%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.48 | 85.94B | ||
CVS | CVS HEALTH CORP | 11.75 | 80.11B | ||
LH | LABCORP HOLDINGS INC | 17.36 | 21.09B | ||
DGX | QUEST DIAGNOSTICS INC | 19.45 | 19.47B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 15.95 | 13.76B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.94 | 12.19B | ||
DVA | DAVITA INC | 15.05 | 11.72B | ||
HIMS | HIMS & HERS HEALTH INC | 73.81 | 8.71B | ||
CHE | CHEMED CORP | 24.04 | 8.25B | ||
CRVL | CORVEL CORP | 26.37 | 5.66B | ||
GH | GUARDANT HEALTH INC | N/A | 4.99B | ||
RDNT | RADNET INC | 97.82 | 4.42B |
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 5,809 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
OPTION CARE HEALTH INC
3000 Lakeside Dr, Suite 300N
Bannockburn ILLINOIS 60015 US
CEO: John C. Rademacher
Employees: 6806
Company Website: https://optioncarehealth.com/
Investor Relations: https://investors.optioncarehealth.com/
Phone: 13129402443
The current stock price of OPCH is 32.63 USD. The price increased by 1.71% in the last trading session.
The exchange symbol of OPTION CARE HEALTH INC is OPCH and it is listed on the Nasdaq exchange.
OPCH stock is listed on the Nasdaq exchange.
16 analysts have analysed OPCH and the average price target is 32 USD. This implies a price decrease of -1.92% is expected in the next year compared to the current price of 32.63. Check the OPTION CARE HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
OPTION CARE HEALTH INC (OPCH) has a market capitalization of 5.55B USD. This makes OPCH a Mid Cap stock.
OPTION CARE HEALTH INC (OPCH) currently has 6806 employees.
OPTION CARE HEALTH INC (OPCH) has a support level at 30.68 and a resistance level at 32.64. Check the full technical report for a detailed analysis of OPCH support and resistance levels.
The Revenue of OPTION CARE HEALTH INC (OPCH) is expected to grow by 15.76% in the next year. Check the estimates tab for more information on the OPCH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OPCH does not pay a dividend.
OPTION CARE HEALTH INC (OPCH) will report earnings on 2025-02-26, before the market open.
The PE ratio for OPTION CARE HEALTH INC (OPCH) is 27.42. This is based on the reported non-GAAP earnings per share of 1.19 and the current share price of 32.63 USD. Check the full fundamental report for a full analysis of the valuation metrics for OPCH.
The outstanding short interest for OPTION CARE HEALTH INC (OPCH) is 2.13% of its float. Check the ownership tab for more information on the OPCH short interest.
ChartMill assigns a technical rating of 9 / 10 to OPCH. When comparing the yearly performance of all stocks, OPCH is one of the better performing stocks in the market, outperforming 88.33% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to OPCH. OPCH has only an average score on both its financial health and profitability.
Over the last trailing twelve months OPCH reported a non-GAAP Earnings per Share(EPS) of 1.19. The EPS decreased by -13.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.37% | ||
ROA | 6.09% | ||
ROE | 14.64% | ||
Debt/Equity | 0.77 |
ChartMill assigns a Buy % Consensus number of 84% to OPCH. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -15.5% and a revenue growth 15.76% for OPCH